Latest Buzz

• Medistem Initiates Collaboration With Chinese Conglomerate Aimed at Clinical Development of Endometrial Regenerative Cells for Critical Limb Ischemia
• Benitec Biopharma and Medistem Technologies Successfully Combined in Preclinical Stem Cell Therapy for Rheumatoid Arthritis
• Medistem and ERCell Initiate Phase II RECOVER-ERC Heart Failure Trial
• Dr. Alan Lewis, Previous CEO of Juvenile Diabetes Research Foundation, Joins Medistem Advisory Board
• Medistem and Licensee ERCell Receive Russian Regulatory Approval for the RECOVER-ERC Trial